Cystinuria: An Overview of Diagnosis and Medical Management
1Department of Pediatrics, University of California, San Francisco, CA, USA.
Insights
Cystinuria, a genetic kidney stone disorder, requires lifelong treatment to prevent chronic kidney disease. New treatments, like alpha-lipoic acid, offer improved management for this common pediatric condition.
Area of Science:
- Nephrology
- Genetics
- Pharmacology
Background:
- Cystinuria is a prevalent monogenic stone disease, affecting 6%-8% of pediatric nephrolithiasis cases.
- Recurrent kidney stone formation in cystinuria leads to a high incidence of chronic kidney disease.
- Effective, long-term medical management is essential for preventing renal failure.
Purpose of the Study:
- To provide a comprehensive overview of cystinuria.
- To emphasize current and emerging medical treatment strategies.
- To highlight the role of novel agents in managing cystinuria.
Main Methods:
- Literature review of cystinuria.
- Analysis of current treatment guidelines.
- Evaluation of novel therapeutic agents, including alpha-lipoic acid.
Main Results:
- Cystinuria necessitates continuous medical intervention to mitigate stone recurrence.
- Alpha-lipoic acid represents a promising new therapeutic option.
- Early and consistent treatment is key to preserving kidney function.
Conclusions:
- Cystinuria management requires a lifelong approach focused on stone prevention.
- Novel pharmacological agents are expanding treatment possibilities.
- Aggressive medical management is crucial for improving patient outcomes and preventing end-stage renal disease.
Abstract:
Cystinuria is a genetic disorder that causes recurrent nephrolithiasis. It is the most common type of monogenic stone disease accounting for 6%-8% of pediatric nephrolithiasis. Due to recurrent episodes of nephrolithiasis, it is associated with a very high prevalence of chronic kidney disease. Life-long medical treatment to reduce stone formation is critical in preventing chronic kidney disease and renal failure in cystinuria. In this article, we provide an overview of cystinuria with a special emphasis on medical treatment options including new agents such as alpha-lipoic acid.
More Related Videos
08:46Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
Published on: September 1, 2015
07:35Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
Related Concept Videos
Urinary Tract Calculi III: Medical Management
Urinary Tract Calculi I: Introduction
Cystic Fibrosis: Management
Sinus disease and chronic...
Nephrotic Syndrome II : Assessment and Medical Management
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Urologic Endoscopic Procedure: Cystoscopic Examination
